chlorambucil and acp-196

chlorambucil has been researched along with acp-196 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's6 (100.00)2.80

Authors

AuthorsStudies
Davids, MS1
Banerji, V; Byrd, JC; Corbett, G; Coutre, S; Cymbalista, F; Egyed, M; Flinn, IW; Fogliatto, LM; Follows, G; Ghia, P; Herishanu, Y; Izumi, R; Janssens, A; Jurczak, W; Kamdar, M; Karlsson, K; Munir, T; Munugalavadla, V; Pagel, JM; Patel, P; Salles, G; Sharman, JP; Skarbnik, A; Walewska, R; Walker, P; Wang, MH; Wierda, WG; Wong, S; Woyach, JA1
Romero, D1
Gao, A; Gao, W; Huo, D; Ran, X; Sheng, Z; Song, S; Yu, M; Zhu, H1
Banerji, V; Byrd, JC; Corbett, G; Coutre, S; Cymbalista, F; Egyed, M; Ferrant, E; Flinn, IW; Fogliatto, LM; Follows, G; Ghia, P; Herishanu, Y; Janssens, A; Jurczak, W; Kamdar, M; Karlsson, K; Munir, T; Munugalavadla, V; Pagel, JM; Sharman, JP; Skarbnik, A; Walewska, R; Walker, P; Wang, MH; Wierda, WG; Woyach, JA; Yu, T1
Gaitonde, P; Genestier, V; Genovez, V; Liljas, B; Munir, T; Ryan, K1

Reviews

1 review(s) available for chlorambucil and acp-196

ArticleYear
Comparison of acalabrutinib plus obinutuzumab, ibrutinib plus obinutuzumab and venetoclax plus obinutuzumab for untreated CLL: a network meta-analysis.
    Leukemia & lymphoma, 2020, Volume: 61, Issue:14

    Topics: Adenine; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bridged Bicyclo Compounds, Heterocyclic; Chlorambucil; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Network Meta-Analysis; Piperidines; Prospective Studies; Pyrazines; Sulfonamides

2020

Trials

1 trial(s) available for chlorambucil and acp-196

ArticleYear
Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzmab for treatment-naive chronic lymphocytic leukaemia (ELEVATE TN): a randomised, controlled, phase 3 trial.
    Lancet (London, England), 2020, 04-18, Volume: 395, Issue:10232

    Topics: Agammaglobulinaemia Tyrosine Kinase; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Chlorambucil; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Progression-Free Survival; Pyrazines

2020

Other Studies

4 other study(ies) available for chlorambucil and acp-196

ArticleYear
Acalabrutinib for the initial treatment of chronic lymphocytic leukaemia.
    Lancet (London, England), 2020, 04-18, Volume: 395, Issue:10232

    Topics: Antibodies, Monoclonal, Humanized; Benzamides; Chlorambucil; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Pyrazines

2020
Acalabrutinib - a new option in CLL.
    Nature reviews. Clinical oncology, 2020, Volume: 17, Issue:7

    Topics: Antibodies, Monoclonal, Humanized; Benzamides; Chlorambucil; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Pyrazines

2020
Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naïve chronic lymphocytic leukemia.
    Leukemia, 2022, Volume: 36, Issue:4

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Chlorambucil; Follow-Up Studies; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Pyrazines

2022
Cost-effectiveness of acalabrutinib regimens in treatment-naïve chronic lymphocytic leukemia in the United States.
    Expert review of pharmacoeconomics & outcomes research, 2023, Volume: 23, Issue:5

    Topics: Aged; Chlorambucil; Cost-Benefit Analysis; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Medicare; Quality-Adjusted Life Years; United States

2023